Uipath is trading at $13.27 (-4.52%), amid investor caution ahead of its second-quarter ARR update.
- No clear company-specific announcement or earnings release explains the August 6, 2026 decline.
- Recent coverage estimates net new ARR will be roughly unchanged year over year.
- Broader technology-sector pressure may be contributing, but modest index moves do not establish causation.